4933. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
作者: Maaike C Swets.;Clark D Russell.;Ewen M Harrison.;Annemarie B Docherty.;Nazir Lone.;Michelle Girvan.;Hayley E Hardwick.; .;Leonardus G Visser.;Peter J M Openshaw.;Geert H Groeneveld.;Malcolm G Semple.;J Kenneth Baillie.
来源: Lancet. 2022年399卷10334期1463-1464页 4937. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
Most countries have made little progress in achieving the Sustainable Development Goal (SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable diseases (NCDs) by a third from 2015 to 2030. In this Health Policy paper, we synthesise the evidence related to interventions that can reduce premature mortality from the major NCDs over the next decade and that are feasible to implement in countries at all levels of income. Our recommendations are intended as generic guidance to help 123 low-income and middle-income countries meet SDG target 3.4; country-level applications require additional analyses and consideration of the local implementation and utilisation context. Protecting current investments and scaling up these interventions is especially crucial in the context of COVID-19-related health system disruptions. We show how cost-effectiveness data and other information can be used to define locally tailored packages of interventions to accelerate rates of decline in NCD mortality. Under realistic implementation constraints, most countries could achieve (or almost achieve) the NCD target using a combination of these interventions; the greatest gains would be for cardiovascular disease mortality. Implementing the most efficient package of interventions in each world region would require, on average, an additional US$18 billion annually over 2023-30; this investment could avert 39 million deaths and generate an average net economic benefit of $2·7 trillion, or $390 per capita. Although specific clinical intervention pathways would vary across countries and regions, policies to reduce behavioural risks, such as tobacco smoking, harmful use of alcohol, and excess sodium intake, would be relevant in nearly every country, accounting for nearly two-thirds of the health gains of any locally tailored NCD package. By 2030, ministries of health would need to contribute about 20% of their budgets to high-priority NCD interventions. Our report concludes with a discussion of financing and health system implementation considerations and reflections on the NCD agenda beyond the SDG target 3.4 and beyond the SDG period.
4938. Extraskeletal Ewing sarcoma of the duodenum presenting as duodenojejunal intussusception.
作者: Razeen Hassan.;Leow Voon Meng.;Kee Thian Ngee.;Lim I-Vern.;Padmaan Sankaran.;Lim Choon Hean.;Lee Euxian.;Haidi Mohamad.;Noraini Mohd Dusa.;Manisekar Subramaniam.
来源: Lancet. 2022年399卷10331期1265页 4939. Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial.
作者: Jacklin F Mosha.;Manisha A Kulkarni.;Eliud Lukole.;Nancy S Matowo.;Catherine Pitt.;Louisa A Messenger.;Elizabeth Mallya.;Mohamed Jumanne.;Tatu Aziz.;Robert Kaaya.;Boniface A Shirima.;Gladness Isaya.;Monica Taljaard.;Jacklin Martin.;Ramadhan Hashim.;Charles Thickstun.;Alphaxard Manjurano.;Immo Kleinschmidt.;Franklin W Mosha.;Mark Rowland.;Natacha Protopopoff.
来源: Lancet. 2022年399卷10331期1227-1241页
Long-lasting insecticidal nets (LLINs) have successfully reduced malaria in sub-Saharan Africa, but their effectiveness is now partly compromised by widespread resistance to insecticides among vectors. We evaluated new classes of LLINs with two active ingredients with differing modes of action against resistant malaria vectors.
|